Phone: (866) 506-2174 | FAX: (352) 401-5650
Search
Close this search box.

Vitamin D in human serum and adipose tissue after supplementation 

Wells Pharmacy Network is a privately held nationwide compounding pharmacy specializing in wellness, anti-aging, weight management, sexual wellness, aesthetic dermatology and thyroid and adrenal health. Our mission is to elevate compounding industry standards through a unique combination of superior science and high-quality compounded products.

Cora M Best, Devon V Riley, Thomas J Laha, Hannah Pflaum, Leila R Zelnick, Simon Hsu, Kenneth E Thummel, Karen E Foster-SchubertJessica N KuzmaGail Cromer… Show moreThe American Journal of Clinical Nutrition, Volume 113, Issue 1, January 2021, Pages 83–91, https://doi.org/10.1093/ajcn/nqaa295 Published: 12 November 2020

ABSTRACT

Background

Serum 25-hydroxyvitamin D [25(OH)D] concentration is an indicator of vitamin D exposure, but it is also influenced by clinical characteristics that affect 25(OH)D production and clearance. Vitamin D is the precursor to 25(OH)D but is analytically challenging to measure in biological specimens.Objectives

We aimed to develop and validate a liquid chromatography–tandem mass spectrometry (LC-MS/MS) method for quantification of vitamins D3 and D2 in serum and to explore the potential of circulating vitamin D as a biomarker of exposure in supplementation trials.Methods

The method was validated using guideline C62-A from the Clinical and Laboratory Standards Institute and was applied in 2 pilot clinical trials of oral vitamin D3 supplementation. Pilot study 1 included 22 adults randomly assigned to placebo or 2000 IU/d. Blood was collected at baseline, 1, 3, 6, and 12 mo. Pilot study 2 included 15 adults randomly assigned to 2000 or 4000 IU/d. Blood and subcutaneous (SUBQ) adipose tissue were collected at baseline and 3 mo.Results

In study 1, mean change (baseline to 3 mo) in serum vitamin D3 was −0.1 ng/mL in the placebo group and 6.8 ng/mL in the 2000 IU/d group (absolute difference: 6.9; 95% CI: 4.5, 9.3 ng/mL). In study 2, mean change (baseline to 3 mo) in serum vitamin D3 was 10.4 ng/mL in the 2000 IU/d group and 22.2 ng/mL in the 4000 IU/d group (fold difference: 2.15; 95% CI: 1.40, 3.37). Serum and adipose tissue vitamin D3 concentrations were correlated, and the dose-response of vitamin D3 in adipose mirrored that in serum.Conclusions

We validated a sensitive, robust, and high-throughput LC-MS/MS method to quantify vitamins D3 and D2 in serum. Serum and SUBQ adipose tissue vitamin D3 concentrations increased proportionally to dose with 3 mo of daily supplementation.

These trials were registered at clinicaltrials.gov as NCT00552409 (pilot study 1) and NCT01477034 (pilot study 2).

To read the original, article here.

Views: 38

Stay Connected!

Sign up for our newsletter and be the first to receive updates on new products, exclusive promotions, industry insights, and more! Don’t miss out on valuable information tailored just for you.

Join Now and stay in the know!